Aditxt News and Activities

View the org chart displaying its 20 main executives

Most searched biographies at Aditxt

• Jeffrey Busch, Interim Chief Executive Officer
• Brian Brady, Director
• Sylvia Hermina, Director

Popular executive movements at Aditxt

• Jeffrey Busch has joined the company as Interim Chief Executive Officer  (posted on June 1 2026).
• Jeff Busch has joined the company as Chief Executive Officer, Ignite Proteomics  (posted on March 19 2026).

Create your alert
to follow the executive moves at Aditxt.

Aditxt has 2,405 competitors including Eurofins (Luxembourg), Lonza (Switzerland) and BioNTech (Germany).

Popular M&A news in Biotechnology

• IMU Biosciences has just announced a $53 Million fundraising (posted on June 3 2026).
• NewLimit has just announced a $435 Million fundraising (posted on June 3 2026).
• Rallybio and Avenzo Therapeutics have announced they will merge  (posted on June 1 2026)..

Popular contacts in Biotechnology

• Jakob Uszkoreit - Co-Founder and Chief Executive Officer at Inceptive
• Jan Van de Winkel - President and Chief Executive Officer at Genmab
• Valerie Hanote - Non-Executive Director at Eurofins

Learn more about the Biotechnology industry

Press releases by Aditxt

• News
• Press Releases

Social media about Aditxt

• Aditxt on Wikipedia, Google News & Yahoo Finance
• Aditxt on LinkedIn, X (Twitter) & YouTube